Adynxx Inc. (ADYX) |
0 (0%)
|
12-31 19:00 |
Open: |
|
Pre. Close: |
|
High:
|
|
Low:
|
|
Volume:
|
|
Market Cap:
|
0M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
0.441 - 0.443 |
0.443 - 0.445 |
Low:
|
0.276 - 0.278 |
0.278 - 0.28 |
Close:
|
0.277 - 0.28 |
0.28 - 0.283 |
|
Technical analysis |
as of: 2021-03-03 4:35:54 PM |
Overall:
|
|
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
Target: |
Six months: 0.56 One year: 0.72 |
Support: |
Support1: 0.24 Support2: 0.20 |
Resistance: |
Resistance1: 0.48 Resistance2: 0.62 |
Pivot: |
0.40  |
Moving Average: |
MA(5): 0.30 MA(20): 0.40 
MA(100): 0.25 MA(250): 0.33  |
MACD: |
MACD(12,26): -0.03 Signal(9): -0.01  |
Stochastic oscillator: |
%K(14,3): 8.47 %D(3): 11.89  |
RSI: |
RSI(14): 44.75  |
52-week: |
High: 2.40 Low: 0.05 Change(%): -74.3 |
Average Vol(K): |
3-Month: 583 10-Days: 294 |
|
Price, moving averages and Bollinger Bands |
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ADYX has closed above bottom band by 27.3%. Bollinger Bands are 70.7% wider than normal. The large width of the bands suggest high volatility as compared to ADYX's normal range. The bands have been in this wide range for 13 bars. This is a sign that the current trend might continue. |
|
Headline News |
Fri, 17 Jul 2020 Exalys Launches With $15M to Treat Postoperative Delirium & More - Xconomy
Thu, 14 Nov 2019 Adynxx Reports Third Quarter 2019 Financial Results Other OTC:ADYX - GlobeNewswire
Mon, 22 Jul 2019 Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market - GlobeNewswire
Wed, 12 Jun 2019 Adynxx Stock to Move to OTC Market Following Receipt of Nasdaq Delisting Notice - Yahoo Finance
Wed, 08 May 2019 Trying to sidestep opioids and pain, Adynxx goes 'reverse merger' route - San Francisco Business Times - San Francisco Business Times
Mon, 06 May 2019 Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors - GlobeNewswire
|
Financial Analysis |
Growth |
 |
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
Profitability |
 |
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
Solvency |
 |
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
Efficiency |
 |
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
Price to Book Value: |
Neutral |
Discounted cash flow: |
Neutral |
Return on Assets: |
Neutral |
Price to Earnings: |
Neutral |
Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: |
Sector: |
Industry: |
Shares Out. (M) |
6 |
Shares Float (M) |
|
% Held by Insiders
|
10.45 |
% Held by Institutions
|
71.81 |
Shares Short (K)
|
26 |
Shares Short P. Month (K)
|
18 |
Stock Financials |
EPS
|
-1.819 |
EPS Est This Year
|
|
EPS Est Next Year
|
|
Book Value (p.s.)
|
-1.900 |
Profit Margin
|
|
Operating Margin
|
|
Return on Assets (ttm)
|
-192.3 |
Return on Equity (ttm)
|
|
Qtrly Rev. Growth
|
|
Gross Profit (p.s.)
|
|
Sales Per Share
|
|
EBITDA (p.s.)
|
-1.355 |
Qtrly Earnings Growth
|
|
Operating Cash Flow (M)
|
-6 |
Levered Free Cash Flow (M)
|
-6 |
Stock Valuations |
PE Ratio
|
-0.15 |
PEG Ratio
|
|
Price to Book value
|
-0.14 |
Price to Sales
|
|
Price to Cash Flow
|
-0.26 |
Stock Dividends |
Dividend
|
|
Forward Dividend
|
|
Dividend Yield
|
|
Dividend Pay Date
|
2019-05-28 |
Ex-Dividend Date
|
2019-05-05 |
7 Binary Options
|
Your Ad Here
|
|